Rossmax International

Rossmax International EBITDA per Employee

The EBITDA per Employee of Rossmax International (4121.TWO) as of Nov 1, 2026 is -75,007.25 TWD. In the previous year, EBITDA per Employee was -79,525.39 TWD — a change of -5.68% (higher).

EBITDA per Employee

-75,007.25TWD

YoY

-5.68%

Last updated:

EBITDA per Employee of Rossmax International is 2025 -75,007.25 TWD. EBITDA per Employee of Rossmax International was 2024 -79,525.39 TWD. It decreases by -5.68% higher compared to the previous year.

The Rossmax International EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
31,852.85 TWD
Jan 1, 2019
61,346.11 TWD
Jan 1, 2020
208,216.58 TWD
Jan 1, 2021
188,038.34 TWD
Jan 1, 2022
308,634.20 TWD
Jan 1, 2023
40,499.48 TWD
Jan 1, 2024
-79,525.39 TWD
Jan 1, 2025
-75,007.25 TWD
The Rossmax International EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-75,007.25TWD-5.68%
-79,525.39TWD-296.36%
40,499.48TWD-86.88%
308,634.20TWD+64.13%
188,038.34TWD-9.69%
208,216.58TWD+239.41%
61,346.11TWD+92.59%
31,852.85TWD-35.03%
49,025.91TWD-138.66%
-126,808.29TWD-3.60%
-131,543.01TWD+29.33%
-101,708.81TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rossmax International Stock analysis

What does Rossmax International do? Rossmax International Ltd, listed on the Taiwan Stock Exchange under ticker 4121.TWO with ISIN TW0004121009, is a healthcare company headquartered in Taipei City, Taiwan. Founded through an IPO on November 28, 2002, the company employs 965 people. It operates within the healthcare sector, focusing on the design, manufacture, research, and development of healthcare products. Its primary product lines include digital sphygmomanometers, respiratory therapy products, temperature series products, and blood oxygen meters. Rossmax distributes its products both domestically within Taiwan and internationally across markets in Europe, the Americas, and other regions. The company maintains a website at https://www.rossmax.com/ for further information. Rossmax International Ltd does not disclose specific financial figures or additional details beyond its operational scope and product offerings as provided in the source material. The company's activities are centered around healthcare innovation and product development aimed at meeting consumer health needs through technological solutions. Rossmax International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rossmax International stock

EBITDA per Employee of Rossmax International is -75,007.25 TWD in 2025.

EBITDA per Employee of Rossmax International changed from -79,525.39 TWD to -75,007.25 TWD, representing a -5.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Rossmax International since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Rossmax International historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Rossmax International

All Key Metrics — Rossmax International